Nephros (NASDAQ: NEPH) — Perfil da empresa, notícias e dados financeiros
Nephros develops high-performance water purification and pathogen detection systems, focusing on healthcare and improving patient outcomes.
Nephros
Nephros (NASDAQ:NEPH) is a company engaged in the development and commercialization of high-performance water purification products and pathogen detection systems for medical and commercial markets. They are focused on addressing the critical need for pure water in healthcare environments, and their product portfolio includes dialysis water purification, and infection control solutions. Nephros aims to improve patient outcomes and provide value through innovative filtration technologies. Their projects include advancing hemodiafiltration technology for kidney dialysis patients and expanding into water safety solutions to combat waterborne pathogens in various settings. With a clear vision towards enhancing water purity and safety, Nephros is committed to delivering cutting-edge solutions to meet the evolving needs of their customers.
Resumo
Operações
Produtos e/ou serviços de Nephros
- Ultrafilters designed for infection control in hospitals, clinics, and commercial buildings to mitigate risks associated with waterborne pathogens.
- Dialysis water purification solutions aimed at enhancing quality in dialysis treatment by removing contaminants and ensuring patient safety.
- Water filtration solutions for military applications, providing portable and reliable water purification methods in challenging environments.
- Medical-grade cold sterilant products intended for use in hospital and clinical settings to ensure sterility of medical instruments and surfaces.
- Advanced water testing services to monitor and evaluate water system contamination levels, ensuring compliance with health standards.
- Water management consulting services, offering expertise in developing, implementing, and managing water safety plans tailored to specific facility needs.
equipe executiva do Nephros
- Robert BanksPresident, CEO & Director
- Judy F. KrandelChief Financial Officer
- Brianne McGuireDirector of Brand, Marketing & Business Development
- Vashone R. ThomasVice President of Quality, Regulatory, & Human Resources
- Greg LucasPresident of Aether Water Systems
- Judy MazziniController
- Michael MilmanVice President of R&D
Principais indicadores financeiros
Resultados divulgados pela Nephros, em USD.
- Cap. de mercado
- 34,5 mi
- Receita (TTM)
- 20,7 mi
- P/L
- 21.1
- LPA (diluído, TTM)
- 0.1
- Dividend yield
- —
- Margem de lucro
- 8.4%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 18,8 mi | 1,1 mi | 1,2 mi | |
| 14,2 mi | 6 mil | 74 mil | |
| 14,2 mi | -1,6 mi | -1,6 mi | |
| 10 mi | -4,3 mi | -7,4 mi |